Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
暂无分享,去创建一个
M. Moriguchi | T. Okanoue | Yuya Seko | K. Yamaguchi | Y. Itoh | T. Hashimoto | Taichiro Nishikawa | A. Umemura | Y. Sumida | K. Yasui | Hiroaki Iijima | Mayumi Kimura